Navigation Links
Rondaxe and TD2 form strategic drug development alliance
Date:2/18/2010

SAN FRANCISCO Feb. 18, 2010 TGen Drug Development (TD2) and Rondaxe Enterprises today announced a strategic alliance that will help emerging companies speed new high-quality treatments to cancer patients.

Rondaxe, a drug development consulting company in Syracuse, N.Y., helps emerging pharmaceutical and biotechnology companies navigate through all phases of the drug development and commercialization process. The company specializes in drug chemistry, manufacturing and controls (CMC), quality assurance and control, regulatory affairs and virtual business development.

TD2, a non-profit Scottsdale subsidiary of the Phoenix-based Translational Genomic Research Institute (TGen), specializes in guiding drug companies through the complexities of setting up and conducting clinical trials, and moving promising drug candidates through the federal review process of the U.S. Food and Drug Administration.

"We are excited to work with Rondaxe, since effective CMC management is key to the successful application and approval processes of the FDA, and moving new anti-cancer treatments to market where they can provide patient benefit," said Dr. Stephen Gately, President and Chief Science Officer at TD2.

Jeffrey M. Evans, Ph.D., co-founder and managing partner of Rondaxe, said, "Our clients will benefit measurably from the 'TD2 Solution' by receiving clear clinical and regulatory development path guidance and service support."

Today's announcement was made during InformexUSA, the world's leading fine and custom chemical industry trade show, which runs through Friday, Feb. 19, at the Moscone Convention Center in downtown San Francisco.

The TD2-Rondaxe alliance is designed to bridge a critical gap between chemistry and translational medicine. This blend of expertise will speed research discoveries through the regulatory process to bring new compounds to patients in a risk-reduced and cost-effective manner. TD2 and Rondaxe teams will focus on maximizing their clients' value proposition throughout the early stages of drug-development.

Rondaxe will provide drug development and manufacturing strategies with expertise in chemical, fermentation, drug product and analytical development, supply chain strategy, manufacturing operations, quality control, and quality assurance.

TD2 offers an integrated suite of tools that includes preclinical support, clinical trials and regulatory affairs, "The TD2 Solution."


'/>"/>

Contact: Steve Yozwiak
syozwiak@tgen.org
602-343-8704
The Translational Genomics Research Institute
Source:Eurekalert

Related biology news :

1. Cogent Systems and Northrop Grumman Reach Agreement to Settle Automated Fingerprint Identification Technology Suit and Create Strategic Alliance
2. Cogent Systems and Northrop Grumman Reach Agreement to Settle Automated Fingerprint Identification Technology Suit and Create Strategic Alliance
3. IBM and ETH Zurich form strategic partnership in nanoscience
4. Cuellars Safe and Lock Announces Strategic Alliance with Absolute Access and Security
5. Strategic farming practices could help mitigate global warming
6. Compendium of pancreatic cancer biomarkers established as strategic approach to early-detection
7. BIO-key(R) Enters Strategic Partnership With Nlets
8. Validus and HierStar Form Strategic Alliance to Offer the First Complete Range of Authentication Products
9. BIO-key(R) Enters Strategic Partnership With Nlets
10. BIO-key Retains Former Senior FBI Official as Strategic Advisor and Consultant
11. Gender, coupled with diabetes, affects vascular disease development
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/14/2017)... 15, 2017  IBM (NYSE: IBM ) is introducing several ... dedicated to developing collaboration between startups and global businesses, taking ... During the event, nine startups will showcase the solutions they ... industries. France is ... with a 30 percent increase in the number of startups ...
(Date:5/16/2017)... 2017  Veratad Technologies, LLC ( www.veratad.com ), an ... identity verification solutions, announced today they will participate as ... 15 thru May 17, 2017, in Washington ... Center. Identity impacts the lives of ... quickly evolving digital world, defining identity is critical to ...
(Date:5/6/2017)... , May 5, 2017 RAM ... announced a new breakthrough in biometric authentication based ... quantum mechanical properties to perform biometric authentication. These new ... semiconductor material created by Ram Group and its ... entertainment, transportation, supply chains and security. Ram Group ...
Breaking Biology News(10 mins):
(Date:9/14/2017)... (PRWEB) , ... September 14, ... ... announces the launch of its CliniControl™ (CC) product portfolio, clinically-relevant starting and ... clinical translation of human Mesenchymal Stem/Stromal Cell (hMSC)-based therapies. The CliniControl product ...
(Date:9/14/2017)... (PRWEB) , ... September 14, 2017 , ... AIM Global, ... Medical Tracking Systems Inc. has won the 2017 Case Study Competition for AIDC. ... which provide benefits that decrease risk” and push the adoption of automated data collection ...
(Date:9/12/2017)... Boston, MA (PRWEB) , ... September 12, 2017 ... ... Physiology Analytics (PPA) and highly scalable cloud-based platform for ambulatory patient monitoring and ... Disruptive Innovations to Advance Clinical Trials conference in Boston. , Launched in ...
(Date:9/12/2017)... ... September 12, 2017 , ... Soybean researchers seeking funding from ... "pre-proposal” by October 15, prior to completing a full grant application. , “The ... our priorities, and to encourage researchers to further develop ones that might need ...
Breaking Biology Technology: